Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"Tiotropium"”.

  1. Cost-Effectiveness and Cost-Utility Analysis of Tiotropium Treatment for Bronchiectasis: Evidence From a Cross Over Randomised Trial

    … the relative cost-effectiveness of administering tiotropium compared to a placebo in adult patients with non-cystic fibrosis (CF) bronchiectasis with airflow obstruction, from a funder perspective. Methods: Clinical efficacy data was obtained from a randomised placebo-controlled crossover study of …

    auckland-tech Repository record for Cost-Effectiveness and Cost-Utility Analysis of Tiotropium Treatment for Bronchiectasis: Evidence From a Cross Over Randomised Trial (opens in a new tab)

  2. Renewed perspective on efficacy and safety of inhaled muscarinic antagonists as asthma management therapies

    … long-acting muscarinic antagonist (LAMA), tiotropium bromide (Spiriva® Respimat®), on the allergen-induced early asthmatic response in thirteen well-controlled mild allergic asthmatics. This investigation used an allergen-inhalation challenge and the indirect measures of inflammation: …

    sask Repository record for Renewed perspective on efficacy and safety of inhaled muscarinic antagonists as asthma management therapies (opens in a new tab)

  3. ANTICHOLINERGIC THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: NOVEL MECHANISMS OF ACTION

    … of novel mechanisms to explore the reported tiotropium bromide-mediated improvement in exercise tolerance in COPD.</p> <p><em>Methods:</em></p> <p>We conducted a retrospective, cross-sectional analysis of 4,424 COPD patients and 4,221 healthy subjects; referred to McMaster University Medical …

    mcmaster Repository record for ANTICHOLINERGIC THERAPY IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE: NOVEL MECHANISMS OF ACTION (opens in a new tab)

  4. Role of long acting bronchodilators in asthma and chronic obstructive pulmonary disease

    … persistent asthma, the addition of the LAMA tiotropium to ICS/LABA adds little to airway calibre or geometry. Neither does it significantly attenuate airway hyperresponsiveness. In the group of smokers with asthma, the addition of tiotropium to ICS/LABA does significantly reduce airway …

    dundee Repository record for Role of long acting bronchodilators in asthma and chronic obstructive pulmonary disease (opens in a new tab) Download PDF for Role of long acting bronchodilators in asthma and chronic obstructive pulmonary disease (opens in a new tab)

  5. Pre-clinical modeling of viral- and bacterial-induced exacerbations of chronic obstructive pulmonary disease

    … the long-acting muscarinic receptor antagonist Tiotropium were tested in the established models. Furthermore, a novel treatment approach using antibodies (Abs) directed against IL-1α, IL-1β or IL-1R1 was examined in the established CS/H1N1 model. Levels of IFN-γ, IL-1β, IL-2, IL-6, KC, TNF-α, …

    wurz-thes Repository record for Pre-clinical modeling of viral- and bacterial-induced exacerbations of chronic obstructive pulmonary disease (opens in a new tab)

  6. The use of MALDI-MS for imaging drug disposition in respiratory disease models.

    … limit of detection. The distribution of a Tiotropium Bromide was monitored throughout the lungs following inhaled delivery. High spatial resolution imaging enabled a detailed view of the distribution of Tiotropium in the trachea and major airways.Quantitative mass spectrometry imaging is a …

    sheffield-hallam Download PDF for The use of MALDI-MS for imaging drug disposition in respiratory disease models. (opens in a new tab)

  7. Ανάπτυξη και βελτιστοποίηση της σύνθεσης ενος DPI με πειραματικό σχεδιασμό: Μια προσέγγιση QbD

    … λειτουργία και μειωμένη ποιότητα ζωής [1-3]. Το Tiotropium είναι ένα αντιχολινεργικό φάρμακο που χορηγείται σε εισπνεόμενη μορφή προκειμένου να ανακουφίσει τα συμπτώματα της Χ.Α.Π. Οι ξηρές κόνεις προς εισπνοή (Dry Powder |Inhalers- DPIs) σε αντίθεση με τους υπόλοιπους τύπους εισπνεόμενων …

    athens Repository record for Ανάπτυξη και βελτιστοποίηση της σύνθεσης ενος DPI με πειραματικό σχεδιασμό: Μια προσέγγιση QbD (opens in a new tab)

  8. The Role of IL-4/IL-13 Signalling in Mucociliary Clearance in Bronchiectasis

    … whereas IL-13 had no significant effect. Tiotropium (an inhibitor of mucus release) did not prevent the IL-4 induced decrease in cilia beat frequency. Finally, this project compared mucus properties in different respiratory conditions. The sputum percentage dry weight, rheology and …

    dundee Repository record for The Role of IL-4/IL-13 Signalling in Mucociliary Clearance in Bronchiectasis (opens in a new tab) Download PDF for The Role of IL-4/IL-13 Signalling in Mucociliary Clearance in Bronchiectasis (opens in a new tab)

  9. Improved inhalation therapies of brittle powders

    … fixed dose therapy using formoterol fumarate, tiotropium bromide and budesonide as therapeutic drugs. We investigated applications of this technology to powder properties and in vitro aerosol performance with respect to single and combination therapy. As a result, the brittle TFF powders …

    texas Repository record for Improved inhalation therapies of brittle powders (opens in a new tab)

  10. Experimental and Numerical Study of Inhaler Spray Characterization (Size Distributions and Velocity)

    … whereas the Spiriva Respimat inhaler using tiotropium bromide. Measurements along the pMDI centerline (at 0, 75, and 100 mm downstream of the inhaler mouthpiece) showed that the spray velocities were bimodal in time for all four pMDI brands. The first peak occurred as the spray was leaving …

    carleton Repository record for Experimental and Numerical Study of Inhaler Spray Characterization (Size Distributions and Velocity) (opens in a new tab)

  11. BRONCHOPROTECTION PROVIDED BY LONG-ACTING MUSCARINIC ANTAGONISTS AND ULTRA LONG-ACTING β2 AGONISTS AGAINST METHACHOLINE-INDUCED BRONCHOCONSTRICTION IN MILD ASTHMATICS

    … of bronchoprotection provided by two LAMAs, tiotropium and glycopyrronium, against methacholine-induced bronchoconstriction in mild asthmatics; the second study had a three-way crossover design for investigating the effects of glycopyrronium (LAMA) and indacaterol (uLABA), alone and in …

    sask Repository record for BRONCHOPROTECTION PROVIDED BY LONG-ACTING MUSCARINIC ANTAGONISTS AND ULTRA LONG-ACTING β2 AGONISTS AGAINST METHACHOLINE-INDUCED BRONCHOCONSTRICTION IN MILD ASTHMATICS (opens in a new tab)

  12. NEW THERAPEUTIC STRATEGY TO CONTRAST INFLAMMATION AND LUNG REMODELLING PROCESSES IN A MURINE MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE

    … and bronchodilators (salmeterol and tiotropium) drugs, at different times: - mice early treated (treatment started at the first week of exposure to risk factors, for 4 weeks); - mice late treated (treatment started at the sixth week of exposure to risk factors, for 4 weeks). …

    milano Repository record for NEW THERAPEUTIC STRATEGY TO CONTRAST INFLAMMATION AND LUNG REMODELLING PROCESSES IN A MURINE MODEL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE (opens in a new tab)